LUMETTI, Federica
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 7.624
AS - Asia 4.986
EU - Europa 3.682
SA - Sud America 702
AF - Africa 117
OC - Oceania 16
Continente sconosciuto - Info sul continente non disponibili 7
Totale 17.134
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 7.397
SG - Singapore 1.473
CN - Cina 1.255
IT - Italia 1.156
GB - Regno Unito 780
BR - Brasile 538
HK - Hong Kong 526
VN - Vietnam 502
SE - Svezia 360
BD - Bangladesh 321
DE - Germania 283
FI - Finlandia 229
FR - Francia 195
KR - Corea 182
IN - India 172
RU - Federazione Russa 171
CA - Canada 123
TR - Turchia 120
ID - Indonesia 116
UA - Ucraina 96
MX - Messico 64
NL - Olanda 60
JP - Giappone 59
AR - Argentina 58
BG - Bulgaria 55
ES - Italia 51
PL - Polonia 46
IQ - Iraq 37
ZA - Sudafrica 37
AT - Austria 33
PK - Pakistan 31
IE - Irlanda 30
MY - Malesia 23
PE - Perù 22
MA - Marocco 21
BE - Belgio 18
CL - Cile 17
CO - Colombia 17
CZ - Repubblica Ceca 17
IR - Iran 17
EC - Ecuador 16
NO - Norvegia 16
RO - Romania 16
AE - Emirati Arabi Uniti 15
SA - Arabia Saudita 15
AU - Australia 14
LT - Lituania 13
TW - Taiwan 13
PY - Paraguay 12
TN - Tunisia 12
VE - Venezuela 12
UZ - Uzbekistan 11
EG - Egitto 10
CH - Svizzera 9
KE - Kenya 9
NP - Nepal 9
AZ - Azerbaigian 8
CR - Costa Rica 8
JO - Giordania 8
GR - Grecia 7
IL - Israele 7
PH - Filippine 7
TH - Thailandia 7
AL - Albania 6
BH - Bahrain 6
DO - Repubblica Dominicana 6
ET - Etiopia 6
HN - Honduras 6
HU - Ungheria 6
KZ - Kazakistan 6
BZ - Belize 5
PT - Portogallo 5
SY - Repubblica araba siriana 5
AO - Angola 4
BB - Barbados 4
BO - Bolivia 4
BY - Bielorussia 4
CY - Cipro 4
DK - Danimarca 4
DZ - Algeria 4
EU - Europa 4
GE - Georgia 4
KG - Kirghizistan 4
KH - Cambogia 4
RS - Serbia 4
AM - Armenia 3
LB - Libano 3
NG - Nigeria 3
OM - Oman 3
SK - Slovacchia (Repubblica Slovacca) 3
SN - Senegal 3
TT - Trinidad e Tobago 3
UY - Uruguay 3
BA - Bosnia-Erzegovina 2
GT - Guatemala 2
HR - Croazia 2
KW - Kuwait 2
LA - Repubblica Popolare Democratica del Laos 2
MD - Moldavia 2
ML - Mali 2
Totale 17.105
Salva come PNG Salva come JPEG
Città #
Santa Clara 977
Singapore 932
Ashburn 811
San Jose 524
Hong Kong 519
Fairfield 445
Southend 415
Chandler 414
Hefei 407
Council Bluffs 253
Woodbridge 251
London 199
Houston 190
Nyköping 190
Beijing 185
Ann Arbor 180
Seoul 170
Helsinki 166
New York 166
Seattle 163
Los Angeles 157
Wilmington 152
Jacksonville 150
Hanoi 146
Ho Chi Minh City 142
Cambridge 135
The Dalles 129
Modena 121
Dearborn 109
Milan 103
Chicago 93
Jakarta 89
San Diego 88
Bologna 80
Lauterbourg 73
Buffalo 62
Princeton 56
Shanghai 56
Izmir 54
Sofia 54
São Paulo 52
Parma 49
Atlanta 48
Moscow 48
Rome 48
Munich 45
Frankfurt am Main 44
Dallas 41
Orem 40
Bremen 39
Tokyo 38
Warsaw 36
Salt Lake City 34
Montreal 32
Naples 32
Toronto 32
Boardman 28
Florence 28
Lappeenranta 28
Delhi 27
Denver 26
Eugene 25
Turin 24
Guangzhou 23
Kent 23
Paris 23
Stockholm 23
Da Nang 22
Haiphong 22
New Delhi 22
Amsterdam 21
Columbus 21
Johannesburg 21
Reggio Emilia 21
Valencia 21
Chennai 20
Dublin 20
Redondo Beach 20
Mumbai 19
Redwood City 19
Mexico City 18
Ottawa 17
Lima 16
Rio de Janeiro 16
Turku 16
Brooklyn 15
Brussels 15
Charlotte 15
Phoenix 15
Manchester 14
San Francisco 14
Vancouver 14
Baghdad 13
Ovada 13
Poplar 13
Querétaro 13
Ankara 12
Boston 12
Elk Grove Village 12
Hillsboro 12
Totale 11.096
Salva come PNG Salva come JPEG
Nome #
Systemic sclerosis progression INvestiGation (SPRING) Italian registry: Demographic and clinico-serological features of the scleroderma spectrum 422
Breast cancer in systemic sclerosis: Results of a cross-linkage of an Italian Rheumatologic Center and a population-based Cancer Registry and review of the literature 370
Established coronary artery disease in systemic sclerosis compared to type 2 diabetic female patients: a cross-sectional study 343
Cardiac involvement in systemic sclerosis: identification of high-risk patient profiles in different patterns of clinical presentation 339
Cardio-pulmonary disease management in patients with systemic sclerosis: cardio-rheumatology clinic and patient care standardisation proposal 329
Serum 25-OH vitamin D levels in systemic sclerosis: analysis of 140 patients and review of the literature 323
Cryoglobulinemic vasculitis and skin ulcers. Our therapeutic strategy and review of the literature 307
Long-term treatment with rituximab in interstitial lung disease related to systemic sclerosis: our clinical experience 303
Predictive value of isolated DLCO reduction in systemic sclerosis patients without cardio-pulmonary involvement at baseline 301
APPLICATION OF CRITERIA FOR THE DIAGNOSIS OF “CLINICAL OSTEOPOROSIS ” IN A POPULATION OF POSTMENOPAUSAL WOMEN FROM EMILIA-ROMAGNA REGION 298
Management of cardiopulmonary disease in patients with systemic sclerosis: cardiorheumatology clinic and patient care standardization proposal 280
Diagnosis and treatment of rheumatoid arthritis in the Emilia Romagna region: a prospective population-based study 279
Beyond cat scratch disease: a case report of bartonella infection mimicking vasculitic disorder 269
Advanced oxidation protein products in serum of patients with systemic sclerosis: a possible indicator of clinical evolution 268
COMPLEMENT DEPLETION IN RHEUMATOID ARTHRITIS PATIENTS TREATED WITH TOCILIZUMAB: A MARKER OF CLINICAL EFFICACY? 267
Use of Neem oil and Hypericum perforatum for treatment of calcinosis-related skin ulcers in systemic sclerosis 257
Photobiomodulation Therapy: A New Light in the Treatment of Systemic Sclerosis Skin Ulcers 255
Rituximab in the treatment of patients with systemic sclerosis. Our experience and review of the literature 254
Autologous Fat Grafting for the Oral and Digital Complications of Systemic Sclerosis: Results of a Prospective Study 254
Adalimumab and ABP 501 in the Treatment of a Large Cohort of Patients with Inflammatory Arthritis: A Real Life Retrospective Analysis 253
Scleroderma Digital Ulcers Complicated by Infection with Fecal Pathogens. 252
Assessing hand grasp in patients with systemic sclerosis using the 16-grasp test: Preliminary results from a multidisciplinary study group 245
RETENTION RATE OF ADALIMUMAB AND ABP 501 IN THE TREATMENT OF A LARGE COHORT OF PATIENTS WITH INFLAMMATORY ARTHRITIS: A REAL LIFE RETROSPECTIVE ANALYSIS 244
A SELF-ADMINISTERED QUESTIONNAIRE MAY ALLOW GENERAL PRACTITIONERS TO PERFORM A RAPID SCREENING TO IDENTIFY PATIENTS AT RISK FOR FRAGILITY FRACTURES AND TO ADDRESS THEM TO BONE METABOLISM SPECIALIZED CLINICAL CENTERS 242
Osteomyelitis complicating scleroderma digital ulcers. 240
Scleroderma skin ulcers definition, classification and treatment strategies our experience and review of the literature 235
AB0611 STRAIN ANALYSIS OF THE RIGHT VENTRICLE USING 2D-SPECKLE TRACKING ECHOCARDIOGRAPHY IN A COHORT OF PATIENTS WITH SYSTEMIC SCLEROSIS 229
Iloprost use and medical management of systemic sclerosis-related vasculopathy in Italian tertiary referral centers: results from the PROSIT study 224
COVID-19 and systemic sclerosis: clinicopathological implications from Italian nationwide survey study 221
Thu0349 autologous fat grafting in the treatment of patients with systemic sclerosis: current experience and future prospects 221
SEVERE VITAMIN D DEFICIENCY IN SYSTEMIC SCLEROSIS 219
Invited Response on: Comments on "Autologous Fat Grafting for the Oral and Digital Complications of Systemic Sclerosis: Results of a Prospective Study" 218
Baseline Ultrasound Assessment Improves the Response to Apremilast in Patients with Psoriatic Arthritis: Results from a Multicentre Study 217
DIGITAL NECROSIS IN SYSTEMIC SCLEROSIS NOT ONLY A MICROVASCULAR DISEASE: A CASE REPORT 215
Predictors of DAPSA Response in Psoriatic Arthritis Patients Treated with Apremilast in a Retrospective Observational Multi-Centric Study (2023-02-07) 207
The predictive role of the TAPSE/sPAP ratio for cardiovascular events and mortality in systemic sclerosis with pulmonary hypertension 206
AB0724 Cardio-pulmonary disease management in patients with systemic sclerosis: cardio-rheumatology clinic and patient care standardisation proposal 205
AB0645 CANNABINOIDS IN THE TREATMENT OF PAIN RELATED TO SYSTEMIC SCLEROSIS SKIN ULCERS: OUR EXPERIENCE 204
Promising use of filgotinib in patients affected by systemic sclerosis: Preliminary data from a case series of 5 patients 204
Altered pathways of keratinization, extracellular matrix generation, angiogenesis, and stromal stem cells proliferation in patients with systemic sclerosis 202
Covid-19 And Rheumatic Autoimmune Systemic Diseases: Role of Pre-Existing Lung Involvement and Ongoing Treatments 202
AB0760 Advanced oxidation protein products in serum of patients with systemic sclerosis: a possible indicator of clinical evolution 200
Molecular Pathways of Breast Cancer in Systemic Sclerosis: Exploratory Immunohistochemical Analysis from the Sclero-Breast Study 199
One-year clinical experience on the use of Nintedanib in Systemic Sclerosis 198
Predictive Value of DLCO Reduction in Scleroderma Patients Without Cardio-Pulmonary Involvement at Baseline 196
Overall mortality in combined pulmonary fibrosis and emphysema related to systemic sclerosis 193
Efficacy and Drug Survival after Switching from Etanercept to the Biosimilar SB4: A Real-Life Long-Term Study 185
Treatment with Rituximab in Systemic Sclerosis Patients: Our Experience in a Pilot Clinical Trial 184
AB0212 LONG-TERM TREATMENT WITH RITUXIMAB IN SYSTEMIC SCLEROSISMANAGEMENT: AN OVERVIEW OF THE CLINICAL EXPERIENCE FROM A REAL-LIFE SETTING 184
EFFICACY OF CERTOLIZUMAB PEGOL FOR DISEASE CONTROL OF PATIENTS AFFECTED BY ENTEROPATHIC SPONDYLARTHRITIS FOLLOWED BY THE JOINT GASTRO-RHEUMATOLOGICAL CLINIC 177
THU0600 a case of systemic sclerosis complicated by renal crisis: potential etiopathogenetic role of cytomegalovirus and treatment 177
From Localized Scleroderma to Systemic Sclerosis: Coexistence or Possible Evolution 175
A New Promising Role for Selexipag in the Treatment of Scleroderma Vasculopathy: Preliminary Results From a Third Level Italian Scleroderma Center 174
Sex-related Differences in Systemic Sclerosis: A Multicenter Cross-sectional Study From the National Registry of the Italian Society for Rheumatology 170
A CALL FOR A COMPREHENSIVE ROLE DEFINITION OF THE STUDY COORDINATOR IN RHEUMATOLOGICAL CLINICAL STUDIES 169
ACCERTAMENTO DELLA DISABILITÀ NELLE MALATTIE REUMATOLOGICHE (EX L.R. N.4 DEL 19 FEBBRAIO 2008) PROPOSTA DI PROTOCOLLO ORGANIZZATIVO 162
Long-term treatment of scleroderma-related digital ulcers with iloprost: a cohort study 160
PROBABILITÀ DI SIEROCONVERSIONE DEL TEST QUANTIFERON DURANTE LA TERAPIA BIOTECNOLOGICA: DATI PRELIMINARI DI UNO STUDIO RETROSPETTIVO CONDOTTO PRESSO L’ARTHRITIS CLINIC DELL’AZIENDA OSPEDALIERO-UNIVERSITARIA POLICLINICO DI MODENA 158
PSYCHIATRIC DISORDERS IN RHEUMATOLOGY: EVALUATION OF A SCREENING PROTOCOL IN 100 HOSPITALIZED PATIENTS 158
KIENBOCK DISEASE IN A PATIENT WITH SSc: A CASE REPORT 157
CYCLING VS SWAP TNFi AND IL17i IN PSORIATIC ARTHRITIS: RESULTS FROM THE BIRRA RETROSPECTIVE OBSERVATIONAL STUDY 155
SAT0285 EVALUATION OF CHRONIC PAIN IN PATIENTS WITH SYSTEMIC SCLEROSIS COMPARED TO THOSE WITH CHRONIC HEADACHE AND RHEUMATOID ARTHRITIS 154
Real life use of prostacyclin analog (Iloprost), a multi-centric survey data from the scleroderma study group Emilia Romagna (Sclero-RER) and review of the literature 145
CONFRONTO TRA STRATEGIE DI TERAPIA AVANZATA DI 2° E 3° LINEA NELLA ARTRITE PSORIASICA: RISULTATI PRELIMINARI DALLO STUDIO OSSERVAZIONE RETROSPETTIVO BIRRA 144
Cycling versus swapping strategieswith TNF-α inhibitors and IL-17 inhibitors in psoriatic arthritis in clinical practice 144
FRI0442 Long-term treatment with rituximab in interstitial lung disease related to systemic sclerosis: our clinical experience 140
Erratum: From Localized Scleroderma to Systemic Sclerosis: Coexistence or Possible Evolution (Dermatology Research and Practice (2018) 2018 (1284687) DOI: 10.1155/2018/1284687) 139
POS0604 JAKi’S SURVIVAL RATE AND PREDICTORS OF DISCONTINUATION IN A COHORT OF PATIENTS WITH RHEUMATOID ARTHRITIS 138
DIFFERENCES BETWEEN SELECTIVE AND UNSELECTIVE JAKi: RESULTS FROM A MULTICENTRIC, REAL LIFE STUDY CARRIED OUT ON PATIENTS WITH RA 132
L’IPERTENSIONE POLMONARE: DALLE NUOVE LINEE GUIDA ALLA PRATICA CLINICA 129
Infections of scleroderma digital ulcers: A single center cohort retrospective study 121
MYCOPHENOLATE MOFETIL TREATMENT REDUCES THE RISK OF TREATMENT ESCALATION DUE TO VASCULAR COMPLICATIONS IN LIMITED CUTANEOUS SYSTEMIC SCLEROSIS: EMULATION OF A TARGET TRIAL FROM ITALIAN RHEUMATOLOGY SOCIETY SPRING REGISTRY 120
Influence of safety warnings on the prescribing attitude of JAK 2inhibitors for rheumatoid arthritis in Italy 118
Effectiveness and Predictors of Long-Term Treatment Response to Tofacitinib in Rheumatoid Arthritis Cohort: General Analysis and Focus on High-Cardiovascular-Risk Subgroup— AMulticenter Study 115
Pulmonary Arterial Hypertension Incidence in Patients With Systemic Sclerosis Treated With Bosentan for Digital Ulcers: Evidence From the SPRING-SIR Registry. 109
OP0063 QUANTITATIVE COMPUTED TOMOGRAPHY PREDICTS 10-YEAR MORTALITY IN INTERSTITIAL LUNG DISEASE RELATED TO SYSTEMIC SCLEROSI 107
Multicenter observational study on the efficacy of selective Janus Kinase-1 inhibitor upatacitinib in rheumatoid arthritis 104
Long-Term Retention Rate of Tofacitinib in Rheumatoid Arthritis: An Italian Multicenter Retrospective Cohort Study 103
Prevalence and clinical relevance of digital ulcers in systemic sclerosis patients from the real-life: the experience of the SPRING Registry of the Italian Society for Rheumatology 99
FRI0651 Quantitative chest ct predicts 8-years-mortality and comorbidity in systemic sclerosis 96
Ixekizumab Retention Rate and Predictors of Treatment Persistence in Psoriatic Arthritis: Results of an Italian Multicenter Study 94
Impact of COVID-19 and vaccination campaign on 1,755 systemic sclerosis patients during first three years of pandemic. Possible risks for individuals with impaired immunoreactivity to vaccine, ongoing immunomodulating treatments, and disease-related lung involvement during the next pandemic phase 92
First-line diagnostic tests to intercept primary heart involvement in systemic sclerosis: Clinical associations from the SPRING-SIR registry 89
Therapeutic Effects of Apremilast on Enthesitis and Dactylitis in Real Clinical Setting: An Italian Multicenter Study 85
Elderly-onset systemic sclerosis defines a distinct clinical subset: analysis from the SPRING registry of the Italian Society for Rheumatology 80
Comparative effectiveness of cycling versus swapping to UL-17 inhibitors after first TNF inhibitor failure in Psoriatic Arthritis: A real- world multicenter study 55
Filgotinib Effectiveness in Rheumatoid Arthritis: Observational Analysis of a Large Multicenter Cohort 50
Menopause in systemic sclerosis: the impact on clinical presentation in a multicenter cross-sectional analysis from the National Registry of the Italian Society for Rheumatology (SPRING-SIR) 45
Gastrointestinal involvement in very early and established systemic sclerosis: insights from the SPRING-SIR national Italian registry. 42
Prevalence, distribution and associations of the scleroderma capillaroscopic patterns: new insights from the Italian SPRING-SIR registry 34
Does Prior Exposure Affect Retention? A Real‑World, Multicentre Assessment of IL‑17 Inhibitor Cycling in Psoriatic Arthritis 32
Guselkumab effectiveness in real-world settings: Observations from an Italian multicentre study 32
Exploring Disease-Specific Risk Factors for Vertebral Fractures in Systemic Sclerosis: Insights from the ScleroRER Study Group 27
Age and onset timing of Raynaud’s phenomenon and first non-Raynaud symptom as prognostic factors in systemic sclerosis: a retrospective analysis from the Italian national multicenter Systemic Sclerosis Progression INvestiGation registry of the Italian Society for Rheumatology (SPRING-SIR) 24
Drug retention of TNF versus IL-23 inhibitors in psoriatic arthritis: a multicenter real-life cohort study 10
Clinical and serological features of triple autoantibody-­ negative patients with systemic sclerosis: insights from the multicentric SPRING registry of the Italian Society for Rheumatology 5
Totale 17.307
Salva come PNG Salva come JPEG
Categoria #
all - tutte 66.065
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 66.065
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202143 0 0 0 0 0 0 0 0 0 0 0 43
2021/20221.160 31 45 86 100 47 88 42 91 150 95 243 142
2022/20231.261 157 147 89 114 127 160 51 119 177 19 51 50
2023/2024970 27 61 47 143 196 55 84 98 23 33 74 129
2024/20253.728 121 52 64 233 740 599 313 198 428 145 343 492
2025/20267.549 482 272 520 909 947 500 898 386 701 762 709 463
Totale 17.307